Clinical Presentation and Outcomes of Autosomal Dominant Polycystic Kidney Disease in the Elderly

Imed Helal^1, , Fatma Lassoued², Hedi Ben Maiz¹ and Adel Kheder¹

¹Department of Medicine A and Laboratory of Kidney Pathology, Charles Nicolle Hospital, Tunis, Tunisia

²Ministry of Public Health, Tunis, Tunisia

Cite this paper:
Imed Helal, Fatma Lassoued, Hedi Ben Maiz and Adel Kheder. Clinical Presentation and Outcomes of Autosomal Dominant Polycystic Kidney Disease in the Elderly. American Journal of Medical Sciences and Medicine. 2013; 1(1):18-20. doi: 10.12691/ajmsm-1-1-3

Abstract

The patient characteristics and outcomes associated with autosomal dominant polycystic kidney disease (ADPKD) have not been characterized in elderly population. The purpose of this study was to delineate clinical presentation and outcome of ADPKD in elderly patients. We performed a retrospective study. Thirty four elderly patients were diagnosed with ADPKD between 1975 and 2005. The diagnosis of ADPKD was made using family history and ultrasound. There were 21 (61.7%) males and 13 (38.3%) females. The mean age at the time of diagnosis of ADPKD was 69.74 ± 3.36 years (range, 65-79 years). The earliest clinical features were renal failure in 67.6%, back pain in 38.2%, and hypertension in 17.6%. Most common form of presentation was hypertension in 70.6%. Kidneys were palpable in 26.5%, and liver was palpable in 32.4%. Left ventricular hypertrophy confirmed by trans-thoracic echocardiography was found in 5(1.5%) patients. Three (0.8%) patients had colonic diverticula and two (0.6%) had neurological manifestation. Twenty six (76.5%) patients had end stage renal disease and 30 (88.2 %) patients had anemia. Median follow-up period for all patients was 17.9 months (range, 1-120 months). Two (0.6%) patients developed renal carcinoma. while five patients (14.7%) died within six years following diagnosis. Anemia was the strongest and an independent predictor of poor renal outcome (p < 0.03). The diagnosis of ADPKD in elderly patients was made late in most cases, with patients already at end stage renal disease. Anemia is risk factor of poor renal prognosis. Early diagnosis and efforts at prevention of the disease progression and complications are most essential.

Keywords:
Autosomal Dominant Polycystic Kidney Disease elderly renal function outcome

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	Iglesias, C., Torres, V., Offord, K., Holley, K., Beard, C. and Kurland L, “Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980”, Am J Kidney Dis, 2(6). 630 -639. May. 1983.
[2]	Iglesias, C., Torres, V., Offord, K., Holley, K., Beard, C. and Kurland L, “Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980”, Am J Kidney Dis, 2(6). 630 -639. May. 1983.
[3]	U.S. Renal Data System: USRDS 2011 Annual Data Report, 2011.
[4]	U.S. Renal Data System: USRDS 2011 Annual Data Report, 2011.
[5]	Counil, E., Cherni, N., Kharrat, M., Achour, A. and Trimech ,H. “Trends of incident dialysis patients in Tunisia between 1992 and 2001”, Am J Kidney Dis, 51(3). 463-70. Mar. 2008.
[6]	Counil, E., Cherni, N., Kharrat, M., Achour, A. and Trimech ,H. “Trends of incident dialysis patients in Tunisia between 1992 and 2001”, Am J Kidney Dis, 51(3). 463-70. Mar. 2008.
[7]	Pretorius, D.H., Lee, M.E., Manco-Johnson, M.L., Weingast, G.R., Sedman, A.B. and Gabow PA, “Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant”, J Ultrasound Med, 6(5). 249–255. May. 1987.
[8]	Pretorius, D.H., Lee, M.E., Manco-Johnson, M.L., Weingast, G.R., Sedman, A.B. and Gabow PA, “Diagnosis of autosomal dominant polycystic kidney disease in utero and in the young infant”, J Ultrasound Med, 6(5). 249-255. May. 1987.
[9]	MacDermot, K.D., Saggar-Malik, A.K., Economides, D.L. and Jeffery S, “Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease”, J Med Genet, 35(1). 13-16. Jan. 1988.
[10]	MacDermot, K.D., Saggar-Malik, A.K., Economides, D.L. and Jeffery S, “Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease”, J Med Genet, 35(1). 13–16. Jan. 1988.
[11]	Gabow, P.A, “Polycystic kidney disease: clues to pathogenesis”, Kidney Int, 40(6). 989-96. Dec. 1991.7. Diouf, B, Dia, D, Ka ,M.M, Ka, E.F, Diop, T.M.” Autosomal dominant polycystosis in the hospital milieu in Dakar (Senegal)”, Dakar Med, 43(2):205-208. Jan 1998.
[12]	Gabow, P.A, “Polycystic kidney disease: clues to pathogenesis”, Kidney Int, 40(6). 989-96. Dec. 1991.7. Diouf, B, Dia, D, Ka ,M.M, Ka, E.F, Diop, T.M.” Autosomal dominant polycystosis in the hospital milieu in Dakar (Senegal)”, Dakar Med, 43(2):205-208. Jan 1998.
[13]	Diouf, B, Dia, D, Ka ,M.M, Ka, E.F, Diop, T.M.” Autosomal dominant polycystosis in the hospital milieu in Dakar (Senegal)”, Dakar Med, 43(2):205-208. Jan 1998.
[14]	Diouf, B, Dia, D, Ka ,M.M, Ka, E.F, Diop, T.M.” Autosomal dominant polycystosis in the hospital milieu in Dakar (Senegal)”, Dakar Med, 43(2):205-208. Jan 1998.
[15]	Cockcroft, D.W. and Gault, M.H, “Prediction of creatinine clearance from serum creatinine”, Nephron, 16(1). 31-41. Jan. 1976.
[16]	Cockcroft, D.W. and Gault, M.H, “Prediction of creatinine clearance from serum creatinine”, Nephron, 16(1). 31-41. Jan. 1976.
[17]	Torres, V. E., Harris, P. C. and Pirson, Y, “Autosomal dominant polycystic kidney disease”, Lancet, 369(9569). 1287-1301. Apr. 2007.
[18]	Torres, V. E., Harris, P. C. and Pirson, Y, “Autosomal dominant polycystic kidney disease”, Lancet, 369(9569). 1287-1301. Apr. 2007.
[19]	Torra, R., Badenas, C., Pérez-Oller, L., Luis, J., Millán, S., Nicolau, C., et al, “Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients”, Am J Kidney Dis, 36(4). 728-34. Oct. 2000.
[20]	Torra, R., Badenas, C., Pérez-Oller, L., Luis, J., Millán, S., Nicolau, C., et al, “Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients”, Am J Kidney Dis, 36(4). 728-34. Oct. 2000.
[21]	Pei, Y., Obaji, J., Dupuis, A., Paterson, A.D., Magistroni, R., Dicks, E. et al, “Unified criteria for ultrasonographic diagnosis of ADPKD”, J Am Soc Nephrol, 20(1). 205-12. Jan. 2009.
[22]	Pei, Y., Obaji, J., Dupuis, A., Paterson, A.D., Magistroni, R., Dicks, E. et al, “Unified criteria for ultrasonographic diagnosis of ADPKD”, J Am Soc Nephrol, 20(1). 205–12. Jan. 2009.
[23]	Milutinovic, J., Fialkow, P.J., Agodoa, L.Y., Phillips, L.A., Rudd, T.G. and Sutherland, S, “Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years”, Am J Kidney Dis, 15(3). 237-43. Mar. 1990.
[24]	Milutinovic, J., Fialkow, P.J., Agodoa, L.Y., Phillips, L.A., Rudd, T.G. and Sutherland, S, “Clinical manifestations of autosomal dominant polycystic kidney disease in patients older than 50 years”, Am J Kidney Dis, 15(3). 237-43. Mar. 1990.
[25]	Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med, 329(5). 332-42. Jul. 1993.
[26]	Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med, 329(5). 332-42. Jul. 1993.
[27]	Montoyo, C., Marinez, M.A., Campo, C., Mazuecos, A., Andrés, A. and Praga, M, “Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease”, Nephron, 61(1). 106-10. Jan. 1992.
[28]	Montoyo, C., Marinez, M.A., Campo, C., Mazuecos, A., Andrés, A. and Praga, M, “Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease”, Nephron, 61(1). 106-10. Jan. 1992.
[29]	Reckelhoff, J.F. and Granger, J.P, “Role of androgens in mediating hypertension and renal injury”, Clin Exp Pharmacol Physiol, 26(2). 127-31. Feb. 1999.
[30]	Reckelhoff, J.F. and Granger, J.P, “Role of androgens in mediating hypertension and renal injury”, Clin Exp Pharmacol Physiol, 26(2). 127-31. Feb. 1999.
[31]	Dedi, R., Bhandari, S., Turney, J.H., Brownjohn, A.M. and Eaidley, I, “Lesson of the week: Causes of hematuria in adult polycystic kidney disease”, BMJ, 323(7309). 386-7. Aug. 2001.
[32]	Dedi, R., Bhandari, S., Turney, J.H., Brownjohn, A.M. and Eaidley, I, “Lesson of the week: Causes of hematuria in adult polycystic kidney disease”, BMJ, 323(7309). 386-7. Aug. 2001.
[33]	Gabow, P.A., Johnson, A.M., Kaehny, W.D., Kimberling, W.J., Lezotte, D.C., Duley, I.T, et al, “Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease”, Kidney Int, 41(5). 1311-9. May. 1992.
[34]	Gabow, P.A., Johnson, A.M., Kaehny, W.D., Kimberling, W.J., Lezotte, D.C., Duley, I.T, et al, “Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease”, Kidney Int, 41(5). 1311-9. May. 1992.
[35]	Johnson, A.M. and Gabow, P.A, “Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease”, J Am Soc Nephrol, 8(10). 1560-7. Oct. 1997.
[36]	Johnson, A.M. and Gabow, P.A, “Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease”, J Am Soc Nephrol, 8(10). 1560-7. Oct. 1997.
[37]	Choukroun, G., Itakura, Y., Albouze, G., Christophe, J.L., Man, N.K., Grünfeld, J.P et al, “Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease”, J Am Soc Nephrol, 6(6). 1634-42. Dec. 1995.
[38]	Choukroun, G., Itakura, Y., Albouze, G., Christophe, J.L., Man, N.K., Grünfeld, J.P et al, “Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease”, J Am Soc Nephrol, 6(6). 1634-42. Dec. 1995.